Prostate Cancer Network, PCaSO have pledged their support to TexRAD’s innovative cancer imaging software which has the ability to detect ‘hidden’ and additional information in scans. PCaSO, which has over 1000 members, had no hesitation in supporting TexRAD and believe that it will be of real benefit to prostate cancer patients.

PCaSO are one of a number of institutions who have expressed their support for TexRAD’s revolutionary software. Hospitals in London, Brighton and Aarhus in Denmark are currently in collaboration with TexRAD as developments continue.